|
RFX7 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.971000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.409000E-01 |
| Normal-vs-Stage2 |
3.668000E-01 |
| Normal-vs-Stage3 |
3.486200E-01 |
| Normal-vs-Stage4 |
7.976800E-01 |
| Stage1-vs-Stage2 |
1.623820E-01 |
| Stage1-vs-Stage3 |
1.532650E-01 |
| Stage1-vs-Stage4 |
5.602400E-01 |
| Stage2-vs-Stage3 |
9.046200E-01 |
| Stage2-vs-Stage4 |
7.428800E-01 |
| Stage3-vs-Stage4 |
7.864400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.189000E-01 |
| Normal-vs-AfricanAmerican |
7.592800E-01 |
| Normal-vs-Asian |
6.443200E-01 |
| Caucasian-vs-AfricanAmerican |
9.628800E-01 |
| Caucasian-vs-Asian |
8.726200E-01 |
| AfricanAmerican-vs-Asian |
8.871000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.025400E-01 |
| Normal-vs-Female |
1.498910E-03 |
| Male-vs-Female |
6.03940000000192E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.200000E-01 |
| Normal-vs-Extreme_Weight |
4.086400E-02 |
| Normal-vs-Obese |
2.524400E-01 |
| Normal-vs-Extreme_Obese |
4.622200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.983900E-02 |
| Normal_Weight-vs-Obese |
7.804000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.608200E-01 |
| Extreme_Weight-vs-Obese |
3.515500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
8.278400E-01 |
| Obese-vs-Extreme_Obese |
2.255200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.565970E-01 |
| Normal-vs-Age(41-60Yrs) |
1.651840E-01 |
| Normal-vs-Age(61-80Yrs) |
6.462400E-01 |
| Normal-vs-Age(81-100Yrs) |
2.686400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.835200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.035190E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.068030E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.645900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.820100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.972100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.130800E-01 |
| Normal-VS-Type2 PRCC |
8.330800E-01 |
| Normal-VS-KIRP CIMP |
3.068200E-02 |
| Normal-VS-Unclassified PRCC |
5.347600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.532200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.396900E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.083900E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.111660E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.054000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.915200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.323800E-01 |
| Normal-vs-N1 |
4.386000E-02 |
| Normal-vs-N2 |
4.948000E-01 |
| N0-vs-N1 |
9.241300E-03 |
| N0-vs-N2 |
1.089610E-01 |
| N1-vs-N2 |
8.909200E-01 |
|
|
